Kirkeby Cell Therapy APS: Financial statements 2018
CVR: 38650165
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Kirkeby Cell Therapy APS (CVR 38650165) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 119,793 and a net result of DKK 71,312. Equity in the 2018 report amounted to DKK 936,547. The solvency ratio was 96.8%.
- Gross Profit
- DKK 119,793
- Profit/Loss
- DKK 71,312
- Equity
- DKK 936,547
- Total Assets
- DKK 967,505
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Kirkeby Cell Therapy APS has published its interim report for the period May 15, 2017 to December 31, 2017.
About Kirkeby Cell Therapy APS
Kirkeby Cell Therapy APS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Kirkeby Cell Therapy IVS and Kirkeby Cell Therapey IVS. The management consists of Agnete Kirkeby. The company is owned by Agnete Kirkeby. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 25,872 and a net result of DKK -19,504 compared with DKK 111,159 the year before. Equity in the 2025 report amounted to DKK 1,541,351.